Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABYSS: Beta blocker interruption after uncomplicated myocardial infarction
2017-003903-23Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of carvedilol in myocardial infarction (MI) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Primary composite MACE endpoint. Started Oct 2017; status: completed.
02
Drugs
carvedilol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2017-003903-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003903-23.